Bruker Daltonics Inc. Announces Schering-Plough Research Institute's Selection of the New solariX FTMS for Structure Characterization and Impurity Testing

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Daltonics announced today that the Rapid Structure Characterization Laboratory (RSCL) of the Schering-Plough Research Institute (SPRI) has selected the new solariX™ FTMS platform from Bruker Daltonics as a cutting-edge tool for structural characterization and purity assessment of pharmaceuticals under development at SPRI. The solariX, with its expansive capabilities, is ideally suited as the ultimate analysis platform to address the rigorous challenges of these application areas in pharmaceutical development.